Figure 3. The reduction of osteoporosis, peripheral fractures and vertebral fractures based on the use of biologic disease-modifying antirheumatic drugs (bDMARDs) (csDMARD, conventional synthetic disease-modifying antirheumatic drugs). Created with BioRender.com.